Company / Shareholders' Equity
InMed Pharmaceuticals Inc. Shareholders' Equity History
FY2022-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Shareholders' Equity
$9.2M
FY2025
5-year range
$7.4M / $12.1M
FY2022-FY2025
Trend
-23.9%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
$9M in FY2025 with a 3-year CAGR of +7.7%.
Remained stable around $9M over the past 2 years.
Shareholders' Equity over time
Growth rates
- 3-Year CAGR
- +7.7%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- 3-year CAGR of +7.7%, indicating consistent growth.
- In FY2025, shareholders' equity decreased 23.9% year-over-year.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Shareholders' EquityValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $9.2M | -23.9% |
| FY2024 | $12.1M | +33.2% |
| FY2023 | $9.1M | +23.1% |
| FY2022 | $7.4M | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026